Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNCOVERED: 3 - Caught on Camera

Sell the Farm on These 4 Cannabis Stocks

Despite significant growth in recent years driven by increased legalization, the cannabis industry took a hit last year amid economic and industry-wide headwinds, including stubborn supply gluts. Furthermore, the industry will likely remain under pressure this year due to economic challenges. Hence, it could be wise to avoid fundamentally weak…

StockNews.com

3 Stocks to Sell Now Before Losses Worsen

Despite the banking industry crisis, the Fed is expected to launch another rate hike next week as it remains committed to bringing inflation down. Therefore, fundamentally weak stocks Snap (SNAP), Peloton Interactive (PTON), and Tilray Brands (TLRY) might be best avoided as they might plunge further. Keep reading.

StockNews.com

2 Risky Cannabis Stocks to Avoid Right Now

Following remarkable growth in recent years, the cannabis industry faced various legal and economic challenges, including overproduction amid high inflation, high taxes, and increased material costs impacting overall sales in 2022. The industry will likely remain under pressure amid concerns over rising inflation and a potential recession. Hence, it could…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Cannabis Stocks to Avoid Like the Plague in March 2023

The cannabis industry faced several challenges last year, including overproduction amid high inflation weighing on overall demand. With growing concerns over rising inflation and a looming recession, the industry is expected to remain under immense pressure this year. So, it could be wise to avoid fundamentally weak cannabis stocks Tilray…

StockNews.com

Marijuana Stocks: Buy or Sell These 3 in 2023?

Although several states have legalized marijuana, the industry faces a supply glut amid high inflation impacting overall demand. With Federal legalization unlikely this year, marijuana stocks could remain under pressure. Therefore, would it be wise to invest in marijuana stocks Tilray Brands (TLRY), Canopy Growth (CGC), and Aurora Cannabis (ACB)…

StockNews.com

Soaring concerns over an impending Fed-induced recession have hampered investor sentiment. With the likelihood of a downturn in upcoming months, are popular stocks Peloton Interactive (PTON), Tilray Brands (TLRY), and ContextLogic (WISH) worth your attention? Read on to find out….

StockNews.com

2 Marijuana Stocks to Sell Short, Liquidate or Avoid in 2023

The marijuana industry took a hit facing economic challenges. With no immediate hope of federal legalization, it may be a while until the U.S. government looks favorably toward pot stocks. Hence, fundamentally weak marijuana stocks Tilray Brands (TLRY) and Canopy Growth (CGC) might be best avoided this year. Continue reading….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

4 Marijuana Stocks to Avoid Like the Plague

While marijuana legalization has been rising, the industry is witnessing increased regulations. Moreover, the sector’s revenues have been declining recently. Hence, marijuana stocks Tilray Brands (TLRY), Canopy Growth (CGC), Sundial Growers (SNDL), and Aurora Cannabis (ACB) might be best avoided, given their weak fundamentals and negative profit margins. Keep reading.

StockNews.com

2 Marijuana Stocks That Are Nothing Short of Buzzkill

While the cannabis industry might be looking at a possible reversal of fortunes due to increased legalization for recreational and proven medicinal usage, fundamentally weak and beaten-down Marijuana stocks Tilray Brands (TLRY) and Canopy Growth (CGC) may be wealth destroyers. So, it could be wise for investors to avoid these…

StockNews.com

Tilray Stock Soars Then Returns To Earth On Biden's Cannabis Pardon News, This Analyst Remains Neutral

On the heels of President Biden’s historic announcement that he was pardoning all federal marijuana possession convictions, Cantor Fitzgerald's

Benzinga

Tilray Net Loss Nearly Doubles From Year Ago, But Biden Marijuana Pardons Keep The Stock Up

Canadian marijuana giant Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) reported Friday financial results for the first fiscal quarter ended August 31, 2022, with net revenue of $153.2 million, which compares to revenue of $168.02 million for the same period last year.

Benzinga

Tilray's SweetWater Brewing Company Unveils New Fall Craft-Beer Lineup

SweetWater Brewing Company, LLC, a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY), announced its fall craft-beer lineup, which includes its new H.A.Z.Y. Double IPA and the return of its Mosaic Single Hop Hazy IPA.

Benzinga

2 Penny Stocks to Avoid Right Now Even at a Discount

With the recent market pullback in the aftermath of Jerome Powell’s speech at Jackson Hole, investors may be tempted to go bottom fishing. However, a rising interest rate environment may not be welcome news for developmental and fund-thirsty businesses with negative cash flows. Thus, given a foreseeably bleak outlook, it…

StockNews.com

3 Cannabis Stocks Going up in Flames to Avoid

The wide use of cannabis for recreational activities and its increased medicinal use has helped the market gain traction over the past years. However, with legalization barriers worldwide, this industry is in an odd limbo in which consumption flourishes, but penalties and taxes still prevail. Given the backdrop, it should…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Is Tilray Still A Bear Play Or Is The Cannabis Giant Ready For A Big Break North?

Tilray Brands, Inc (NASDAQ: TLRY) was spiking up over 6% on Monday, attempting to break up from a falling channel on the daily chart, which the stock began trading in on Aug. 8.

Benzinga

EXCLUSIVE: Tilray CEO Shares Insider Insights Into Earnings, International Opportunities, Alcohol Market & More

Tilray Brands Inc.'s (NASDAQ: TLRY) CEO Irwin Simon said on Thursday's "Cannabis Insider" that "Europe will legalize [cannabis] before the U.S."

Benzinga

Tilray Goes Through With It: Closes $155M Investment In HEXO, Expects $80M In Shared Savings

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) has closed its acquisition from HT Investments MA LLC (“HTI”) of the secured convertible note issued by HEXO Corp. (NASDAQ: HEXO

StockNews.com

Why Investors Are Starting to Turn Bullish on This 1 Stock

Medical cannabis producer Tilray Brands (TLRY) seems to be attracting investors’ attention lately due to its recent product launches. However, its price target has recently been slashed by Piper Sandler (PIPR). Let’s discuss its prospects in detail.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Tilray's Broken Coast Launches New Summer Lineup Of Cannabis Products

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) is expanding Broken Coast’s cannabis portfolio with the launch of their summer lineup of products, including: premium craft-cannabis BC (British Columbia) flower, liquid wax vapes and butane hash o

Benzinga

What 4 Analyst Ratings Have To Say About Tilray Brands

Within the last quarter, Tilray Brands (NASDAQ:TLRY) has observed the following analyst ratings:

Benzinga

Cannabis On Amazon? Why Tilray Stock Is Trading Higher

Tilray Brands Inc (NASDAQ: TLRY) shares are trading higher Thursday after the company announced the launch of its CBD lifestyle brand POLLEN on the Amazon.com Inc (NASDAQ: AMZN) UK platform.

Benzinga

Tilray Launches New CBD Lifestyle Brand, POLLEN Gummies & Drink Drops Available On Amazon UK

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced the launch of POLLEN, a CBD lifestyle brand with a new approach to wellness, on Amazon UK.

Benzinga

Tilray's Good Supply Brand Expands High-Potency Cannabis Portfolio, Here Are The Details

Tilray Brands, Inc. (Nasdaq: TLRY) (TSX:TLRY) is expanding Good Supply's cannabis portfolio with the launch of new high-potency products including liquid wax vapes and exclusive new

Benzinga

Jim Cramer Shares His Thoughts On Fluor, Tilray Brands And More

On CNBC’s "Mad Money Lightning Round," Jim Cramer said stocks, including Tilray Brands, Inc. (NASDAQ: TLRY) are impossible to own until the Fed legalizes cannabis.

Benzinga

Tilray's Breckenridge Distillery Wins Two Double Gold And One Gold Medal At The San Francisco World Spirits Competition

Breckenridge Distillery, subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY), celebrates two Double Gold and one Gold medal at the 2022 San Francisco World Spirits Competition.

1 2 3 4 5

People

Mangeet Kaur BounsMangeet

Sristi Suman Jayaswal

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical – Pharmaceuticals

69 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.